This is a working overview of lipolysis, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2026-07-03. Anything still debated is marked as such rather than presented as settled.
Tesamorelin is a synthetic peptide that belongs to the growth hormone-releasing hormone family and contains the same forty-four amino acid sequence as endogenous GHRH, extended at the amino terminus by a trans-3-hexenoyl group. That small fatty acid modification protects the peptide from rapid cleavage by dipeptidyl peptidase-4, the enzyme that shortens the half-life of native GHRH to only a few minutes. Chemically the compound is produced by solid-phase peptide synthesis, purified by chromatography, and supplied as a sterile lyophilized powder for reconstitution.
Regulatory approval in the United States came in 2010, when the Food and Drug Administration cleared the peptide for the reduction of excess abdominal fat in adults with HIV infection and associated lipodystrophy. The decision rested mainly on two randomized phase 3 trials that enrolled roughly eight hundred patients and ran for twenty-six weeks. Participants receiving active drug showed substantially greater declines in visceral adipose tissue than those receiving placebo, while total body weight changed comparatively little. A reformulated presentation was later approved, and the product has remained a niche therapy rather than a general weight-loss agent.
Tesamorelin occupies a narrow position among agents that act on the growth hormone axis. Unlike growth hormone itself, which is given as replacement, it stimulates the pituitary to release the hormone in pulses, so the downstream increase in insulin-like growth factor 1 depends on intact somatotroph function. Other peptides in the same family include shorter GHRH fragments and synthetic secretagogues with different stability profiles. Several points remain unresolved, including whether the reduction in visceral fat translates into fewer cardiovascular events, what happens to metabolic markers after long-term use, and how the drug compares with lifestyle or surgical approaches.
Stimulated growth hormone release leads to hepatic production of insulin-like growth factor 1, a key mediator of many growth hormone effects. In clinical studies, tesamorelin increased IGF-1 levels in a dose-dependent manner, although the response varies among individuals. The drug's effect on visceral fat is thought to involve growth hormone-mediated lipolysis and altered adipocyte metabolism. Muscle mass and lean body mass have also been assessed as secondary outcomes, but changes are generally smaller and less consistent than fat reductions.
Pharmacodynamic studies show that tesamorelin reduces visceral adipose tissue more than subcutaneous adipose tissue in the studied population. This selectivity may relate to differences in blood flow and hormone sensitivity between fat depots. Effects on glucose metabolism and insulin sensitivity have been investigated, with some trials reporting modest changes and others showing stability. The precise relationship between growth hormone exposure, IGF-1 levels, and visceral fat loss remains an active area of analysis.
Tesamorelin binds to growth hormone-releasing hormone receptors on somatotroph cells in the anterior pituitary. Receptor activation increases intracellular cyclic AMP and promotes synthesis and secretion of growth hormone. Because the peptide mimics endogenous GHRH, it amplifies the normal pulsatile release of growth hormone rather than providing exogenous growth hormone directly. This upstream action distinguishes tesamorelin from recombinant growth hormone preparations and from growth hormone secretagogues that act at different receptors.
| Property | Value | Notes |
|---|---|---|
| Peptide class | Synthetic GHRH analogue | 44 residues; N-terminal trans-3-hexenoyl group |
| First approval year | 2010 | United States; HIV-associated abdominal fat accumulation |
| Administration route | Subcutaneous injection | Abdominal site; clinician-administered or self-injected |
| Common synonyms | TH9507; tesamorelin acetate | Development code and acetate salt form |
| Originator | Canadian biotechnology firm | Original developer and regulatory sponsor |
A documented effect of tesamorelin is a reduction in visceral adipose tissue in some study populations. Researchers have reported decreases in trunk fat measured by computed tomography alongside changes in lipid markers. The mechanism is thought to involve growth hormone-mediated lipolysis, though the precise contribution of direct versus indirect pathways is not fully resolved. Studies have generally examined defined groups over finite periods, so long-term outcomes are less well characterized. Findings have not been uniform across all trials.
Tesamorelin is a synthetic peptide analog of growth hormone-releasing hormone (GHRH). Its sequence corresponds to the 44-amino-acid form of human GHRH with a trans-3-hexenoyl group attached to the N-terminal tyrosine. This modification slows enzymatic cleavage and extends the peptide's activity relative to the native hormone. The compound is produced by solid-phase peptide synthesis and supplied as a lyophilized powder. Researchers classify it as a GHRH receptor agonist. Its structure places it in the same family as other growth hormone secretagogues that act on the pituitary.
Binding of tesamorelin to GHRH receptors on pituitary somatotroph cells triggers cyclic AMP signaling and the release of growth hormone into circulation. Because the peptide acts upstream of the growth hormone axis, its effects are partly mediated by hepatic insulin-like growth factor 1 (IGF-1) production. The pulsatile character of endogenous growth hormone secretion is preserved rather than replaced. Whether amplified signaling produces effects beyond those of native GHRH remains an area of ongoing investigation.
Measuring the effect of a growth hormone-releasing hormone analogue requires markers that reflect pituitary output rather than the peptide itself. The two most frequently used are growth hormone and insulin-like growth factor 1. Growth hormone fluctuates sharply across the day and responds to sleep, stress, and meals, so isolated readings can be difficult to interpret. Insulin-like growth factor 1 changes more slowly and is often treated as the more stable integrated marker of axis activity.
Because growth hormone is released in pulses, single measurements can misrepresent overall secretion. Investigators sometimes use repeated sampling or overnight profiles to capture the pattern rather than a single value. Provocative testing, in which a stimulus is given and the response is tracked over time, offers another way to characterize the axis. Each approach carries trade-offs between sensitivity, burden on the participant, and the influence of non-target variables.
On 18 August 2015, following a 112-point loss to Adelaide in Round 20, 2015—and a dismal season overall for the Essendon Football Club, by which time they had a 5–14 win–loss record and were fifteenth on the AFL ladder—Hird resigned as senior coach.
== See also == C-terminal telopeptide, commonly known as CTX, a serum biomarker for bone turnover rate and a tool used to evaluate patient risk for complications due to BRONJ Osteonecrosis of the jaw, see section on Bisphosphonates Osteoradionecrosis, a term for osteonecrosis caused by radiotherapy Phossy jaw
Haemovigilance – incident management, investigation, follow-up, and reporting Risk management including writing, implementing, updating and monitoring local policies and procedures Blood management education Monitoring and providing feedback on activities related to compliance with best practice guidelines including auditing Change management activities Appropriate use and management including waste minimisation Assisting with the implementation of PBM strategies
Airline meal Camping food Combat Capabilities Development Command Soldier Center – prime developer of the MRE Individual Meal Pack – Canadian equivalent to the MRE List of military food topics Lunchables Meal kit Military chocolate Ninja diet Space food
Sources: en.wikipedia.org
=== Anna Gearing === Anna Gearing (Elena Saurel) is the head of FutureDawn Partners, a socially conscious investment fund. Despite her ethical business philosophy, Anna is shown to have expensive personal tastes, and micromanages employees at her fund. She has two daughters, with her longtime portfolio manager Petra Koenig as their godmother. Anna first appears as a client of Pierpoint, with Yasmin Kara-Hanani hedging her FX exposure. Harper meets Anna at a Pierpoint-organized duck shoot in Wales tied to healthcare startup Rican, where Anna bluntly assesses Rican as fundamentally underperforming and incapable of delivering on its social mission. Harper uses this insight to convince Jesse Bloom to buy out Anna’s stake—after already selling him $3.3 billion in shares—securing his controlling interest and long-term profit. After Harper is fired from Pierpoint, she joins FutureDawn as Anna’s executive assistant, but quickly aligns herself with Petra, who grows disillusioned with Anna’s leadership. Tensions peak when Harper helps Petra hedge Lumi IPO exposure by buying credit default swaps on fossil-fuel assets, directly contradicting FutureDawn’s ethical stance. Harper and Petra ultimately break away to form their own hedge fund, publicly announcing the move at a Swiss climate conference attended by Anna.
Bukele passed a law in 2021 that made bitcoin legal tender in El Salvador and promoted plans to build Bitcoin City. In June 2023, the Legislative Assembly approved Bukele's proposals to reduce the number of municipalities from 262 to 44 and the number of seats in the legislature from 84 to 60. He ran for re-election in the 2024 presidential election and won with 85 percent of the vote after the Supreme Court of Justice reinterpreted the constitution's ban on consecutive re-election. Bukele is highly popular in El Salvador and throughout Latin America. He holds an average approval rating of 88.6% during his entire presidency with approval ratings never having fallen below 75%. El Salvador has experienced democratic backsliding under Bukele's leadership, falling 61 places in the World Press Freedom Index between 2019 and 2025 and 24 places in the Economist Intelligence Unit's Democracy Index, which now classifies El Salvador as a hybrid regime. In February 2020, Bukele ordered 40 soldiers into the Legislative Assembly building to intimidate lawmakers into approving a US$109 million loan for the Territorial Control Plan, an event that triggered a political crisis and was described by the opposition as a self-coup. After Nuevas Ideas won a supermajority in the 2021 legislative election, Bukele's allies in the legislature voted to replace the attorney general and all five justices of the Supreme Court of Justice's Constitutional Chamber. Bukele has criticized journalists and news outlets, and has furthered press censorship.
Iraqi authorities announce that the US transferred the diplomatic and logistics hub at Baghdad International Airport to Iraq prior to the withdrawal of American soldiers from the country. Chinese leader Xi Jinping meets Trump at the White House during his first visit to Washington in a decade. The two leaders discuss trade, artificial intelligence, Taiwan and international conflicts, and agree to extend the existing US–China trade truce by two months. September 25 – Cities and states across the United States, including Lexington, Nashville, New Orleans, and Portland, hold commemorations honoring former American country singer Dolly Parton including the 9 to 5 song one month after her death. California becomes the first U.S. state to designate September 25 as Dolly Parton Day. September 26 A powerful nor'easter strikes the northeast United States. A New York City Housing Authority employee is killed by a falling tree in Brooklyn. Trump rejects Iran's seven-day ceasefire proposal over nuclear concerns. The Wall Street Journal reports that he privately expects U.S. bombing to resume after the midterm elections in November, although the scale remains undecided amid dwindling munitions stockpiles. September 27 – Trump says that he still expected more talks to resume with Iran during the week. Trump claims that Iran "wanted to make a deal," but they "overplayed their hand" by offering conditions that the US "would have maybe agreed to a year ago." September 28 SpaceX's Starship achieves orbit for the first time, and deploys 26 "next generation" Starlink V3 satellites.
The radioactivity of all radioactive waste weakens with time. All radionuclides contained in the waste have a half-life—the time it takes for half of the atoms to decay into another nuclide. Eventually, all radioactive waste decays into non-radioactive elements (i.e., stable nuclides). Since radioactive decay follows the half-life rule, the rate of decay is inversely proportional to the duration of decay. In other words, the radiation from a long-lived isotope like iodine-129 will be much less intense than that of a short-lived isotope like iodine-131. The two tables show some of the major radioisotopes, their half-lives, and their radiation yield as a proportion of the yield of fission of uranium-235. The energy and the type of the ionizing radiation emitted by a radioactive substance are also important factors in determining its threat to humans. The chemical properties of the radioactive element will determine how mobile the substance is and how likely it is to spread into the environment and contaminate humans. This is further complicated by the fact that many radioisotopes do not decay immediately to a stable state but rather to radioactive decay products within a decay chain before ultimately reaching a stable state.
== Medical uses == Regular insulin is used for the long-term management of diabetes. It is the treatment of choice for the two diabetic emergencies diabetic ketoacidosis and hyperosmolar hyperglycemic states. It may also be used in combination with glucose to lower potassium levels in those with hyperkalemia.
Sources: en.wikipedia.org
The chemical energy stored in ATP (the bond of its third phosphate group to the rest of the molecule can be broken, allowing more stable products to form, thereby releasing energy for use by the cell) can then be used to drive processes requiring energy, including biosynthesis, locomotion, or transportation of molecules across cell membranes.
The Bowery () is a street and neighborhood in Lower Manhattan in New York City, New York. The street runs from Chatham Square at Park Row, Worth Street, and Mott Street in the south to Cooper Square at 4th Street in the north. The eponymous neighborhood runs roughly from the Bowery east to Allen Street and First Avenue, and from Canal Street north to Cooper Square/East Fourth Street. The neighborhood roughly overlaps with Little Australia. To the south is Chinatown, to the east are the Lower East Side and the East Village, and to the west are Little Italy and NoHo. It has historically been considered a part of the Lower East Side of Manhattan. In the 17th century, the road branched off Broadway north of Fort Amsterdam at the tip of Manhattan to the homestead of Peter Stuyvesant, director-general of New Netherland. The street was known as Bowery Lane prior to 1807. "Bowery" is an anglicization of the Dutch bouwerie, derived from an antiquated Dutch word for "farm": In the 17th century the area contained many large farms. The New York City Subway's Bowery station, serving the BMT Nassau Street Line (J and Z trains), is located close to the Bowery's intersection with Delancey and Kenmare Streets. There is a tunnel under the Bowery at Confucius Plaza, intended for use by a never-completed portion of the Second Avenue Subway. The M103 bus runs on the entire Bowery.
=== Nucleotide biosynthesis === Nucleotides serve as the building blocks for nucleic acids, DNA and RNA. They are composed of a nitrogenous base, a pentose sugar, and at least one phosphate group. Nucleotides contain either a purine or a pyrimidine nitrogenous base. All intermediates in purine biosynthesis are constructed on a R5P "scaffold". R5P also serves as an important precursor to pyrimidine ribonucleotide synthesis. During nucleotide biosynthesis, R5P undergoes activation by ribose-phosphate diphosphokinase (PRPS1) to form phosphoribosyl pyrophosphate (PRPP). Formation of PRPP is essential for both the de novo synthesis of purines and for the purine salvage pathway. The de novo synthesis pathway begins with the activation of R5P to PRPP, which is later catalyzed to become phosphoribosylamine, a nucleotide precursor. During the purine salvage pathway, phosphoribosyltransferases add PRPP to bases.
== Human defensins == Initially human alpha defensin peptides were isolated from the neutrophils and are thus called human neutrophil peptides. Human neutrophil peptides are also known as α-defensins. Human neutrophil-derived alpha-defensins (HNPs) are capable of enhancing phagocytosis by mouse macrophages. HNP1-3 have been reported to increase the production of tumor necrosis factor (TNF) and IL-1, while decreasing the production of IL-10 by monocytes. Increased levels of proinflammatory factors (e.g., IL-1, TNF, histamine and prostaglandin D2) and suppressed levels of IL-10 at the site of microbial infection are likely to amplify local inflammatory responses. This might be further reinforced by the capacity of some human and rabbit alpha-defensins to inhibit the production of immunosuppressive glucocorticoids by competing for the binding of adrenocorticotropic hormone to its receptor. Moreover, human alpha-defensins can enhance or suppress the activation of the classical pathway of complement in vitro by binding to solid-phase or fluid-phase complement C1q, respectively. The capacity of defensins to enhance phagocytosis, promote neutrophil recruitment, enhance the production of proinflammatory cytokines, suppress anti-inflammatory mediators and regulate complement activation argues that defensins upregulate innate host inflammatory defenses against microbial invasion. Human neutrophil defensin-1, -3, and -4 are elevated in nasal aspirates from children with naturally occurring adenovirus infection.
Sources: en.wikipedia.org
It is a laboratory-made peptide of forty-four amino acids whose sequence matches human growth hormone-releasing hormone, with a modified amino terminus. The modification is a short unsaturated fatty acid chain attached to the first residue. This change slows enzymatic breakdown and lengthens the time the peptide stays active in circulation.
The clinical program was designed around HIV-associated lipodystrophy, a condition in which fat accumulates abnormally around the internal organs. Trials enrolled that specific population, so the evidence base covers it rather than the general population. Regulators approved the drug for the studied indication only, and promotion outside it is not permitted.
Growth hormone therapy supplies the finished hormone directly, while this peptide acts upstream and asks the pituitary to secrete its own. That difference means the response depends on a functioning pituitary and on the body's normal feedback loops. It also means the circulating hormone profile is pulsatile rather than a flat, injected level.
It targets the growth hormone-releasing hormone receptor on pituitary somatotroph cells. Binding stimulates cyclic AMP signaling and growth hormone secretion. This is the same receptor used by endogenous GHRH.